EANDI, Mario. Cost-effectiveness analysis of paclitaxel + carboplatin vs. alternative combinations in the treatment of non-small cell lung cancer. Farmeconomia. Health economics and therapeutic pathways, [S. l.], v. 7, n. 2, p. 97–117, 2006. DOI: 10.7175/fe.v7i2.680. Disponível em: https://provafe.seedstm.com/index.php/FE/article/view/680. Acesso em: 23 jul. 2025.